Table 3 Standardised incidence ratios (SIR) for total and site-specific cancers among 14 088 patients with a primary diagnosis of Parkinson's disease, 1977–1998
From: Atypical cancer pattern in patients with Parkinson's disease
Site of cancer (ICD-7) | No. observed | No. expected | SIR | 95% CI |
|---|---|---|---|---|
All sites combined (140–205) | 1282 | 1463.9 | 0.88 | 0.8–0.9 |
Melanoma of skin (190) | 44 | 22.5 | 1.95 | 1.4–2.6 |
Other skin (191) | 292 | 234.4 | 1.25 | 1.1–1.4 |
All sites except skin | 990 | 1229.5 | 0.81 | 0.8–0.9 |
Breast | 142 | 114.6 | 1.24 | 1.0–1.5 |
All sites except skin and breast | 804 | 1092.4 | 0.74 | 0.7–0.8 |
All smoking-related sites | 285 | 491.3 | 0.58 | 0.5–0.6 |
Lung (162.0–1) | 66 | 174.8 | 0.38 | 0.3–0.5 |
Larynx (161) | 5 | 10.7 | 0.47 | 0.2–1.1 |
Urinary bladder (181) | 50 | 95.3 | 0.52 | 0.4–0.7 |
Buccal cav., pharynx (140–148) | 15 | 24.6 | 0.61 | 0.3–1.0 |
Esophagus (150) | 10 | 15.2 | 0.66 | 0.3–1.2 |
Myeloid leukaemia (204, partly) | 10 | 14.4 | 0.69 | 0.3–1.3 |
Liver | 10 | 14.4 | 0.70 | 0.3–1.3 |
Cervix uteri (171) | 10 | 13.1 | 0.76 | 0.4–1.4 |
Stomach (151) | 39 | 47.0 | 0.83 | 0.6–1.1 |
Pancreas (157) | 37 | 44.6 | 0.83 | 0.6–1.1 |
Kidney (180) | 33 | 37.2 | 0.89 | 0.6–1.3 |
Other specified sites | 422 | 521.3 | 0.81 | 0.7–0.9 |
Gallbladder | 9 | 14.5 | 0.62 | 0.3–1.2 |
Ovary (175) | 15 | 23.3 | 0.64 | 0.4–1.1 |
Multiple myeloma (203) | 12 | 17.3 | 0.69 | 0.4–1.2 |
Other leukaemias (204, partly) | 16 | 22.4 | 0.71 | 0.4–1.2 |
Prostate (177) | 90 | 121.9 | 0.74 | 0.6–0.9 |
Non-Hodgkin's lymphoma (200, 202) | 23 | 30.0 | 0.77 | 0.5–1.2 |
Colon (153) | 120 | 142.2 | 0.84 | 0.7–1.0 |
Endometrium (172) | 23 | 26.6 | 0.87 | 0.6–1.3 |
Rectum (154) | 63 | 70.5 | 0.89 | 0.7–1.1 |
Brain (193) | 31 | 23.5 | 1.32 | 0.9–1.9 |
Remaining specified sites | 20 | 29.1 | 0.69 | 0.4–1.1 |
Secondary and unspecified sites | 97 | 80.1 | 1.21 | 1.0–1.5 |
